KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and MSP Recovery (NASDAQ:MSPR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.
Profitability
This table compares KORU Medical Systems and MSP Recovery’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -6.41% | -15.90% | -9.77% |
| MSP Recovery | -7,328.48% | -326.80% | -81.27% |
Risk and Volatility
KORU Medical Systems has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.9, indicating that its stock price is 390% less volatile than the S&P 500.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KORU Medical Systems | $41.13 million | 4.97 | -$2.64 million | ($0.06) | -73.50 |
| MSP Recovery | $9.81 million | 0.04 | -$360.50 million | ($572.83) | 0.00 |
KORU Medical Systems has higher revenue and earnings than MSP Recovery. KORU Medical Systems is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent recommendations for KORU Medical Systems and MSP Recovery, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 1 | 4 | 0 | 2.50 |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
KORU Medical Systems presently has a consensus price target of $6.50, indicating a potential upside of 47.39%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, equities analysts clearly believe KORU Medical Systems is more favorable than MSP Recovery.
Institutional & Insider Ownership
58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 3.8% of MSP Recovery shares are owned by institutional investors. 20.6% of KORU Medical Systems shares are owned by insiders. Comparatively, 50.5% of MSP Recovery shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
KORU Medical Systems beats MSP Recovery on 12 of the 14 factors compared between the two stocks.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
